Potassium channel opener-augmented cardioplegia: Protection of myocyte contractility with chronic left ventricular dysfunction

Circulation

Volumn 96, Issue 9 SUPPL., 1997, Pages

  Dorman, B Hugh ^b   Hebbar, Latha ^b   Clair, Mark J ^b   Hinton, Robert B ^b   Roy, Raymond C ^b   Spinale, Francis G ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APRIKALIM; CALCIUM ION; CARDIOPLEGIC AGENT; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CARDIOPLEGIA; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE REPERFUSION; HEART PROTECTION; HYPERKALEMIA; NONHUMAN; PRIORITY JOURNAL; SWINE;

ANIMALS; CALCIUM; CHRONIC DISEASE; HEART ARREST, INDUCED; HEART FAILURE, CONGESTIVE; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION; PICOLINES; POTASSIUM CHANNELS; PYRANS; SWINE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0343990047     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Roberts AJ, Spies SM, Sanders JH, Moran JM, Wilkinson CJ, Lichtenthal PR, White RL, Michaelis LL. Serial assessment of left ventricular performance following coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1981;81:69-84.
2. Weisel RD. Myocardial stunning after coronary bypass surgery. J Cardiovasc Surg. 1993;8:242-244.
3. Weintraub WS, Wenger NK, Jones EL, Craver JM, Guyton RA. Changing clinical characteristics of coronary surgery patients. Circulation. 1993;88(suppl II):79-86.
4. Auchampach JA, Maruyama M, Cavero I, Gross GJ. Pharmacological evidence for a role of ATP-dependent potassium channels in myocardial stunning. Circulation. 1992;86:311-319.
5. Grover GJ. Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia. J Cardiovasc Pharmacol. 1994;24:S18-S27.
6. Auchampach JA, Gross GJ. Anti-ischaemic actions of potassium channel openers in experimental myocardial ischaemia/reperfusion injury in dogs. Eur Heart J. 1993;14:10-15.
7. Maskal SL, Cohen NM, Hsia PW, Wechsler AS, Damiano RJ. Hyperpolarized cardiac arrest with the potassium-channel opener, aprikalim. J Thorac Cardiovasc Surg. 1995;110:1083-1095.
8. Cohen NM, Wise RM, Wechsler AS, Damiano RJ. Elective cardiac arrest with a hyperpolarizing adenosine triphosphate-sensitive potassium channel opener. J Thorac Cardiovasc Surg. 1993;106: 317-328.
9. Cohen NM, Damiano RJ, Wechsler AS. Is there an alternative to potassium arrest? Ann Thorac Surg. 1995;60:858-863.
10. Damiano RJ, Cohen NM. Hyperpolarized arrest attenuates myocardial stunning following global surgical ischemia: an alternative to traditional hyperkalemic cardioplegia? J Cardiovasc Surg. 1994;9: 517-525.
11. Lawton JS, Sepic JD, Allen CT, Hsia PW, Damiano RJ. Myocardial protection with potassium-channel openers is as effective as St. Thomas' solution in the rabbit heart. Ann Thorac Surg. 1996;62: 31-39.
12. Damiano RJ Jr. The electrophysiology of ischemia and cardioplegia: implications for myocardial protection. J Cardiovasc Surg. 1995;10(suppl 4):445-453.
13. Menasché P, Mouas C, Grousset C. Is potassium channel opening an effective form of preconditioning before cardioplegia? Ann Thorac Surg. 1996;61:1764-1768.
14. Sugimoto S, Puddu PE, Monti F, Schiariti M, Campa PP, Marino B. Pretreatment with the adenosine triphosphate-sensitive potassium channel opener nicorandil and improved myocardial protection during high-potassium cardioplegic hypoxia. J Thorac Cardiovasc Surg. 1994;108:455-466.
15. Handy JR, Spinale FG, Mukherjee R, Crawford FA. Hypothermie potassium cardioplegia impairs myocyte recovery of contractility and inotropy. J Thorac Cardiovasc Surg. 1994;107:1050-1058.
16. Walker JD, Crawford FA, Spinale FG. 3,5,3′ Triiodo-L-thyronine pretreatment with cardioplegic arrest and chronic left ventricular dysfunction. Ann Thorac Surg. 1995;60:292-299.
17. 2+ and β-adrenergic stimulation. Anesthesiology. 1995;82:926-939.
18. Spinale FG, Crawford FA, Hewett KW, Carabello BA. Ventricular failure and cellular remodeling with chronic supraventricular tachycardia. J Thorac Cardiovasc Surg. 1991;102:874-882.
19. Spinale FG, Fulbright BM, Mukherjee R, Tanaka R, Hu J, Crawford FA, Zile MR. Relation between ventricular and myocyte function with tachycardia-induced cardiomyopathy. Circ Res. 1992; 71:174-187.
20. Tanaka R, Fulbright FM, Mukherjee R, Burchell SA, Crawford FA, Zile MR, Spinale FG. The cellular basis for the blunted response to β-adrenergic stimulation in supraventricular tachycardia-induced cardiomyopathy. J Mol Cell Cardiol. 1993;25:1215-1233.
21. Spinale FG, Mukherjee R, Fulbright BM, Hu J, Crawford FA, Zile MR. Contractile properties of isolated porcine ventricular myocytes. Cardiovasc Res. 1993;27:304-311.
22. Zile MR, Mukherjee R, Clayton C, Kato S, Spinale FG. Effects of chronic supraventricular pacing tachycardia on relaxation rate in isolated cardiac muscle cells. Am J Physiol. 1995;268:H2104-H2113.
23. + channel modulator aprikalim (RP 52891): improved cardioprotection in isolated ischemic rabbit hearts. Can J Physiol Pharmacol. 1994;72:126-132.
24. Henry P, Escande D. Do potasium channel openers compete with ATP to activate ATP sensitive potassium channels? Cardiovasc Res. 1992;86;311-319.
25. 2+ handling associated with the inverse force-frequency relation in human dilated cardiomyopathy. Circulation. 1995;92: 1169-1178.
26. 2+ transport and mechanics in compensated pressure-overload hypertrophy and congestive heart failure. Circ Res. 1995;77;759-764.
27. Meyer M, Schillinger W, Pieske B, Holubarsch C, Heilmann C, Psival H, Kuwajima G, Mikoshiba K, Just H, Hasenfuss G. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation. 1995;92;778-784.
28. 2+ and contractility in cardiac and vascular smooth muscles. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The Heart and Cardiovascular System. New York, NY: Raven Press; 1992:903-944.
29. 2+ uptake during post-ischemic reperfusion in the isolated rat heart: influence of extracellular sodium. J Mol Cell Cardiol. 1982;14:359-365.
30. 2+ overload and depressed recovery of ventricular function of reperfused ischemic rat hearts. Circ Res. 1989;65:1045-1056.
31. Quaife RA, Kohmoto D, Barry WH. Mechanisms of reoxygenation injury in cultured ventricular myocytes. Circulation. 1991;83: 566-577.
32. Boli R. Mechanism of myocardial stunning. Circulation. 1990;82: 723-738.
33. 2+ in stunning? Cardiovasc Drug Ther. 1991;5:891-893.
34. 2+ waves: a laser confocal microscopy study. Am J Physiol. 1996;270:H1384-H1389.
35. 2+ loading of cardiac cells: possible implications in cardioplegia. J Thorac Cardiovasc Surg. 1996;112:820-831.
36. Kirvatis RJ, Krukenkamp IB, Levitsky S. The cellular pathways involved in pharmacological preconditioning are mediated through a codependent interrelationship of the ATP-sensitive potassium channel and protein kinase C. Circulation. 1996;94:I-392. Abstract.
37. Sugden PH, Bogoyevitch MA. Intracellular signalling through protein kinases in the heart. Cardiovasc Res. 1995;30:478-495.
38. Steinberg SF, Goldberg M, Rybin VO. Protein kinase C isoform diversity in the heart. J Mol Cell Cardiol. 1995;27:141-153.
39. Spinale FG, Holzgrefe HH, Mukherjee R, Hird RB, Walker JD, Arnim-Barker A, Powell JR, Koster WH. Angiotensin converting enzyme inhibition and the progression of congestive cardiomyopathy: effects on left ventricular and myocyte structure and function. Circulation. 1995;92:562-568.
40. Spinale FG, Tempel GE, Mukherjee R, Eble DM, Brown R, Vacchiano C, Zile MR. Cellular and molecular changes in the β-adrenergic receptor system with supraventricular tachycardia induced cardiomyopathy. Cardiovasc Res. 1994;28:1243-1250.
41. Bristow MR, Ginsburg R, Umans V, Fowler M, Minobe W, Rasmussen R, Zera P, Menlove R, Shah P, Jamieson S, Stinson EB. β1 and β2 adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective β1-receptor down regulation in heart failure. Circ Res. 1986;59:297-309.
42. Schwinn DA, Leone BJ, Spahn DR, et al. Desensitization of myocardial β-adrenergic receptors during cardiopulmonary bypass: evidence for early uncoupling and late down regulation. Circulation. 1991;84:2559-2567.
43. Schranz D, Droege A, Broede A, Brodermann, Schafer E, Oelert H, Brodde OE. Uncoupling of human cardiac β-adrenoceptors during cardiopulmonary bypass with cardioplegic cardiac arrest. Circulation. 1993;87:422-426.
44. Tsutsui H, Spinale FG, Nagatsu M, Nagatsu M, Schmid PG, Ishihara K, DeFreyte G, Cooper G, Carabello B. The effects of chronic β-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic mitral regurgitation. J Clin Invest. 1994;93:2639-2648.
45. Wang Z, Lam CF, Mukherjee R, Hebbar L, Wang Y, Spinale FG. Relation between external load and isolated myocyte contractile function. Am J Physiol. 1997;273:H183-H191.